https://www.nature.com/articles/d41586-023-00212-z
0
0
1/27/23 at 11:49am
Organization
Nature.com
34 words
0
Comments
Pfizer, GSK and Moderna are ahead in the race to produce vaccines against respiratory syncytial virus — what will be their impact?
You are the first to view
Create an account
or login to join the discussion